Mimedx (MDXG) Change in Receivables (2011 - 2026)
Mimedx recorded quarterly Change in Receivables of -$28.2 million in Q1 2026, down 3280.27% quarter-over-quarter from $887000.0 in Q4 2025, and down 491.63% year-over-year from $7.2 million in Q1 2025.
Mimedx's Change in Receivables history runs 15 years deep, the most recent figure standing at -$28.2 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 491.63% year-over-year to -$28.2 million; the TTM figure through Mar 2026 stood at -$9.0 million (down 240.66% YoY), while the FY2025 annual figure was $26.4 million, up 934.25% from the prior year.
- Change in Receivables came in at -$28.2 million for Q1 2026 at Mimedx, down from $887000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $11.0 million in Q3 2025 to a low of -$28.2 million in Q1 2026.
- A 5-year average of $1.1 million and a median of $2.4 million in 2022 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables sank 89200.0% in 2022 and surged 1055.72% in 2025, its largest moves.
- Mimedx's Change in Receivables stood at $2.6 million in 2022, then soared by 111.13% to $5.6 million in 2023, then slumped by 59.61% to $2.3 million in 2024, then plunged by 60.63% to $887000.0 in 2025, then slumped by 3280.27% to -$28.2 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$28.2 million, $887000.0, and $11.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -28.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.21 Mn |
| Mar 31, 2026 | -28.21 Mn |
| Dec 31, 2025 | 887,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Sep 30, 2025 | 11.01 Mn |
| Sep 30, 2025 | 11.01 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 953,000.00 |
| Sep 30, 2024 | 953,000.00 |
| Jun 30, 2024 | -4.00 Mn |
| Jun 30, 2024 | -4.00 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 489,000.00 |
| Sep 30, 2023 | 489,000.00 |
| Jun 30, 2023 | 4.62 Mn |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Dec 31, 2022 | 2.64 Mn |
| Dec 31, 2022 | 2.64 Mn |
| Sep 30, 2022 | 3.60 Mn |
| Sep 30, 2022 | 3.60 Mn |
| Jun 30, 2022 | 2.38 Mn |
| Jun 30, 2022 | 2.38 Mn |
| Mar 31, 2022 | -2.68 Mn |
| Mar 31, 2022 | -2.68 Mn |
| Dec 31, 2021 | 9.51 Mn |
| Dec 31, 2021 | 9.51 Mn |
| Sep 30, 2021 | -707,000.00 |
| Sep 30, 2021 | -707,000.00 |
| Jun 30, 2021 | 1.82 Mn |
| Jun 30, 2021 | 1.82 Mn |
| Mar 31, 2021 | -3,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Dec 31, 2020 | 2.38 Mn |
| Dec 31, 2020 | 2.38 Mn |
| Sep 30, 2020 | 2.95 Mn |
| Sep 30, 2020 | 2.95 Mn |
| Jun 30, 2020 | -1.84 Mn |
| Jun 30, 2020 | -1.84 Mn |
| Mar 31, 2020 | -395,000.00 |
| Mar 31, 2020 | -395,000.00 |
| Dec 31, 2019 | 10.94 Mn |
| Dec 31, 2019 | 10.94 Mn |
| Dec 31, 2017 | 5.64 Mn |
| Dec 31, 2017 | 5.64 Mn |
| Sep 30, 2017 | 1.25 Mn |
| Sep 30, 2017 | 1.25 Mn |
| Jun 30, 2017 | -6.11 Mn |
| Jun 30, 2017 | -6.11 Mn |
| Mar 31, 2017 | -305,000.00 |
| Mar 31, 2017 | -305,000.00 |
| Dec 31, 2016 | -7.74 Mn |
| Dec 31, 2016 | -7.74 Mn |
| Sep 30, 2016 | 8.57 Mn |
| Sep 30, 2016 | 8.57 Mn |
| Jun 30, 2016 | 980,000.00 |
| Jun 30, 2016 | 980,000.00 |
| Mar 31, 2016 | -1.87 Mn |
| Mar 31, 2016 | -1.87 Mn |
| Dec 31, 2015 | 6.98 Mn |
| Dec 31, 2015 | 6.98 Mn |
| Sep 30, 2015 | 7.33 Mn |
| Sep 30, 2015 | 7.33 Mn |
| Jun 30, 2015 | 8.45 Mn |
| Jun 30, 2015 | 8.45 Mn |
| Mar 31, 2015 | 4.33 Mn |
| Mar 31, 2015 | 4.33 Mn |
| Dec 31, 2014 | 3.37 Mn |
| Dec 31, 2014 | 3.37 Mn |
| Sep 30, 2014 | 2.81 Mn |
| Sep 30, 2014 | 2.81 Mn |
| Jun 30, 2014 | 1.53 Mn |
| Jun 30, 2014 | 1.53 Mn |
| Mar 31, 2014 | 2.87 Mn |
| Mar 31, 2014 | 2.87 Mn |
| Dec 31, 2013 | 2.39 Mn |
| Dec 31, 2013 | 2.39 Mn |
| Sep 30, 2013 | 1.94 Mn |
| Sep 30, 2013 | 1.94 Mn |
| Jun 30, 2013 | 1.94 Mn |
| Jun 30, 2013 | 1.94 Mn |
| Mar 31, 2013 | 2.17 Mn |
| Mar 31, 2013 | 2.17 Mn |
| Dec 31, 2012 | 1.48 Mn |
| Dec 31, 2012 | 1.48 Mn |
| Sep 30, 2012 | 2.22 Mn |
| Sep 30, 2012 | 2.22 Mn |
| Jun 30, 2012 | 1.09 Mn |
| Jun 30, 2012 | 1.09 Mn |
| Mar 31, 2012 | 961,633.00 |
| Mar 31, 2012 | 961,633.00 |
| Dec 31, 2011 | 390,354.00 |
| Dec 31, 2011 | 390,354.00 |
| Sep 30, 2011 | 259,058.00 |
| Sep 30, 2011 | 259,058.00 |
| Jun 30, 2011 | 709,409.00 |
| Jun 30, 2011 | 709,409.00 |
| Mar 31, 2011 | -150,365.00 |
| Mar 31, 2011 | -150,365.00 |